logo

Thyroseq V3 Molecular Testing For Fine Needle Aspiration Biopsy Samples Of Thyroid Nodules

Sector: Commercial • Location: Bethesda, Maryland, United States of America

Source: SAM.gov

Tender
Solicitation

This is a combined synopsis/solicitation for commercial items prepared in accordance with FAR Subpart 12.6, as supplemented with additional information included in this notice. This announcement constitutes the only solicitation; proposals are being requested, and a separate written solicitation will not be issued. The solicitation number is 75N98026Q00822. This solicitation is issued as a competi

Status
Prospective
Sector
Commercial, Government, Residential, Hospital
Location
Bethesda, Maryland, United States of America
Updated
3 Nov 2026
Source
SAM.gov

ConstructChat

Ask ConstructChat about Thyroseq V3 Molecular Testing For Fine Needle Aspiration Biopsy Samples Of Thyroid Nodules

Pick a question to edit it, or write your own.

First answer free · no account

I am a

Tender Information FAQ

Tender Information

3 Q
The tender “Thyroseq V3 Molecular Testing For Fine Needle Aspiration Biopsy Samples Of Thyroid Nodules” is a tender record in Taiyo, linked to the Commercial sector. It is issued for works, goods, or services related to Bethesda, Maryland, United States of America.

Participants

Not available for this record.

Status

Original status

solicitation

Taiyo status

Prospective

Taiyo last update

2026-11-03

Contact

Not available for this record.

Description

Description

This is a combined synopsis/solicitation for commercial items prepared in accordance with FAR Subpart 12.6, as supplemented with additional information included in this notice. This announcement constitutes the only solicitation; proposals are being requested, and a separate written solicitation will not be issued. The solicitation number is 75N98026Q00822. This solicitation is issued as a competitive combined synopsis/solicitation for commercial products or commercial services. The Government intends to award a contract or purchase order resulting from this solicitation using full and open competition. This acquisition is conducted under the authority of FAR 12.603, Streamlined Solicitation for Commercial Products or Commercial Services, and is not expected to exceed the simplified acquisition threshold of $350,000.00. The National Institutes of Health (NIH), Office of the Director, Office of Acquisitions, seeks to award a Firm-Fixed-Price to the responsible offeror whose proposal represents the best value to the Government. The solicitation document and incorporated provisions and clauses are those in effect through Federal Acquisition Circular 2026-01 March 13, 2026. The associated NAICS code is 621511, and the small business size standard is 41,500,000 employees. This requirement is NOT A SET-ASIDE for small businesses. Description of Requirement: Thyroseq testing for 20 nodules per year for the fiscal year 2026 The provision at FAR 52.212-1, Instructions to Offerors—Commercial Items, applies to this acquisition. Add any agency-specific instructions as required. The provision at FAR 52.212-2, Evaluation—Commercial Items, applies to this acquisition. The Government will award a contract resulting from this solicitation to the responsible offeror whose offer conforming to the solicitation represents the best value to the Government, price and other factors considered. Evaluation Factors: Technical capability Price Past performance Delivery schedule A written notice of award or acceptance of an offer, issued within the time specified in the offer, shall result in a binding contract without further action by either party. The Government reserves the right to accept any offer before the expiration date. Offerors shall include a completed copy of FAR 52.212-3, Offeror Representations and Certifications—Commercial Items, with their offer. FAR 52.212-4, Contract Terms and Conditions—Commercial Items, applies to this acquisition. FAR 52.212-5, Contract Terms and Conditions Required to Implement Statutes or Executive Orders—Commercial Items, applies to this acquisition. Submission Requirements: Responses must include sufficient information to demonstrate the offeror’s capability to provide the required product or service. Quotes shall include, at a minimum: Unit and total price Shipping and handling costs Delivery timeframe after award Delivery terms F.O.B. point (destination) Product or catalog numbers (if applicable) Product/service description Additional evaluation considerations may include past performance, warranty, lifecycle cost, maintenance availability, and environmental or energy efficiency. Responses must include the Unique Entity Identifier (UEI), Taxpayer Identification Number (TIN), and business size certification. All offerors must be actively registered in the System for Award Management (SAM) at www.sam.gov. All responses must be received by July 27, 2026 at 9:00 AM and must reference solicitation number 75N98026Q00822. Responses may be submitted electronically to James.Law@nih.gov. Point of Contact: James Law James.law@nih.gov

Original sector

Health Care and Social Assistance

Location

Country

United States of America (USA)

State

Maryland

City

Bethesda

Source

Source

SAM.gov

URL

More Details

Record type

Tender

Sector

Commercial, Government, Residential, Hospital

Article published date

2026-07-18

More on this tender

Research

Free account

View all details

You are reading the public part. A free account opens the rest:

  • Every detail on this tender
  • News and media coverage
  • Technical research
View all details

Free account · no card · lands you back on this tender